glp 1 drugs kidney disease Glucagon-like peptide-1 receptor agonists in diabetic disease: A review of their kidney and heart protection Glucagon-like Peptide Receptor Agonists and

2002 May;36(5):812-6

J., Wu, Z

Consider referral to an endocrinologist for: Pregnancy planning or current pregnancy Persistently abnormal TSH despite adherence to treatment Presence of thyroid nodules, goiter, or compressive symptoms Rapid changes in thyroid size or function Diagnostic uncertainty or complex thyroid disease Patients with diabetes and pre-existing retinopathy who are starting semaglutide should also coordinate with an ophthalmologist for appropriate monitoring

Review our triple-agonist mechanism guide for detailed receptor analysis

That makes it theoretically safer metabolically compared to growth hormone